Search

Author/Creator Loiselle, C.

1. P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WITHOUT BLINATUMOMAB, IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATES FROM A PHASE II TRIAL. (23rd June 2022)

Authors:
Haddad, F.; Kantarjian, H.; Short, N.; Ravandi, F.; Jain, N.; Macaron, W.; Kadia, T.; Alvarado, Y.; Daver, N.; Borthakur, G.; DiNardo, C.; Konopleva, M.; Wierda, W.; Jacob, J.; Roy, E.; Loiselle, C.; Milton, A.; Rivera, J.; Garris, R.; Jabbour, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Kantarjian, H.; Short, N.; Alvarado, Y.; Burger, J.; Jain, N.; Konopleva, M.; Ravandi, F.; DiNardo, C.; Masarova, L.; Sasaki, K.; Thompson, P. A.; Ferrajoli, A.; Jacob, J. O.; Mayor, E. D.; Milton, A. M.; Loiselle, C.; Garris, R. S.; Jabbour, E. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P369: A PHASE II STUDY OF MINI-HYPER-CVD PLUS VENETOCLAX IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Kantarjian, H.; Short, N.; Konopleva, M.; Ravandi, F.; Jain, N.; Thompson, P. A.; Pemmaraju, N.; Wierda, W. G.; Borthakur, G.; Kadia, T. M.; Garcia-Manero, G.; Yilmaz, M.; Thankachan, J.; Zhao, M.; Loiselle, C.; Talley, M. T.; Kwari, M. I.; Garris, R. S.; Jabbour, E. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Short, N.; Kantarjian, H.; Ravandi, F.; Yilmaz, M.; Kadia, T.; Thompson, P.; Huang, X.; Konopleva, M.; Ferrajoli, A.; Jain, N.; Sasaki, K.; Alvarado, Y.; Borthakur, G.; Dinardo, C.; Ohanian, M.; Macaron, W.; Kornblau, S.; Zhao, M.; Kwari, M.; Loiselle, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY. (23rd June 2022)

Authors:
Short, N.; Kantarjian, H.; Konopleva, M.; Jain, N.; Ravandi, F.; Huang, X.; Macaron, W.; Wierda, W.; Borthakur, G.; Kadia, T.; Sasaki, K.; Issa, G.; Montalban-Bravo, G.; Alvarado, Y.; Garcia-Manero, G.; Dinardo, C.; Thankachan, J.; Delumpa, R.; Mayor, E.; Deen, W.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search